Statistics for E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor-Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research Group

Total visits

views
E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor-Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research Group 0

Total visits per month

views
January 2025 0
February 2025 0
March 2025 0
April 2025 0
May 2025 0
June 2025 0
July 2025 0

File Visits

views
java.util.UUID:89b96e54-cccb-4cdb-9dac-fa276f8bf540 7